HDAC2 and pancreatic ductal adenocarcinoma: The higher sensitivity of colon cancer cells lacking wild-type HDAC2 is also in agreement with the observation that a knockdown of HDAC2 in pancreatic ductal adenocarcinoma (PDAC) has no effect on cell viability but sensitizes PDAC cell lines to etoposide-induced apoptosis [37].